Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103476 · ClinicalTrials.gov registry record · Phase 2
Advancing Postmenopausal Preventive Therapy
A Phase 2 study of Atherosclerosis and Cognitive Decline, sponsored by University of Southern California.
- Active
- Registry status
- Phase 2
- Development phase
- 385
- Enrollment target
- 1
- Study location
NCT04103476: Active Phase 2 study of Atherosclerosis and Cognitive Decline, sponsored by University of Southern California.
NCT04103476 is a Phase 2 study of Atherosclerosis and Cognitive Decline that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 385 participants, below the 1,060-participant average among 69 other Atherosclerosis trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04103476, a Phase 2 study of Atherosclerosis and Cognitive Decline, is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 385 participants
- Enrollment target
- 1
- Study location
Study Summary
Advancing Postmenopausal Preventive Therapy (APPT) is a randomized, double-blinded, placebo-controlled trial designed to determine the effects of tissue selective estrogen complex (TSEC) therapy on the progression of subclinical atherosclerosis and cognitive decline in 360 healthy postmenopausal women.
Primary Outcome
Rate of change in carotid artery intima-media thickness (CIMT) determined from the distal common carotid artery (CCA) far wall intima-media thickness (IMT) in computer image processed B mode ultrasonograms.
Conditions Studied
Interventions
- OTHER Placebo
- COMBINATION_PRODUCT Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg
Study Locations (1)
California
- University of Southern California Atherosclerosis Research Unit - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2021-04-13 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What the registry record for NCT04103476 still lists
NCT04103476 is an interventional study that assigns participants to a tested intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap, below the 1,060-participant average among 69 other Atherosclerosis trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Atherosclerosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04103476 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04103476 about?
NCT04103476 is a clinical study titled "Advancing Postmenopausal Preventive Therapy". Advancing Postmenopausal Preventive Therapy (APPT) is a randomized, double-blinded, placebo-controlled trial designed to determine the effects of tissue selective estrogen complex (TSEC) therapy on the progression of subclinical atherosclerosis and cognitive decline in 360 healthy postmenopausal wom...
What is the current status of trial NCT04103476?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 385 participants. The study started on 2021-04-13. Estimated completion is 2026-12-31.
What conditions does trial NCT04103476 study?
This clinical trial studies the following conditions: Atherosclerosis, Cognitive Decline.
What interventions are being tested in trial NCT04103476?
The interventions under investigation include: Placebo (OTHER), Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04103476?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103476 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04103476's enrollment target sits among peer trials
385 22nd of 69 higher than 48 of 69 other Atherosclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atherosclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RECRUITING · Phase 2
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RECRUITING · Phase 2
-
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
COMPLETED · Phase 2
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
COMPLETED · Phase 2
-
VEAPS: Vitamin E Atherosclerosis Prevention Study
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI